S. Man

H. Kitchener, A. Fiander, S. Man, 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

ANALYSIS OF THE ALLOREACTIVE T CELL REPERTOIRE IN MAN: I. DIFFERENCES IN PRECURSOR FREQUENCY FOR CYTOTOXIC T CELL RESPONSES AGAINST ALLOGENEIC MHC MOLECULES IN UNRELATED INDIVIDUALS

S. Man, J. Batchelor, C. Sharrock, 1987, Transplantation.

Use of an anti‐CD200‐blocking antibody improves immune responses to AML in vitro and in vivo

A. Gilkes, S. Knapper, M. Wong, 2020, British journal of haematology.

Individual variation in the frequency of HLA class II‐specific cytotoxic T lymphocyte precursors

R. Lechler, S. Man, C. Sharrock, 1990, European journal of immunology.

Anti‐viral cytotoxic T cells inhibit the growth of cancer cells with antibody targeted hla class I/peptide complexes in scid mice

G. Ogg, A. McMichael, A. Clayton, 2002, International journal of cancer.

HCMV pUL135 Remodels the Actin Cytoskeleton to Impair Immune Recognition of Infected Cells

J. Haas, M. Weekes, P. Tomasec, 2014, Cell host & microbe.

Immunology of human papillomavirus infection in lower genital tract neoplasia.

A. Fiander, S. Man, Stephen Man, 2001, Best practice & research. Clinical obstetrics & gynaecology.

Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia

J. Cerhan, T. Shanafelt, S. Slager, 2016, American journal of hematology.

The role of humoral and cellular immunity in patients developing human anti-murine immunoglobulin antibody responses after radioimmunotherapy.

C. Kosmas, S. Man, N. Courtenay-Luck, 1990, The British journal of cancer. Supplement.

Increased frequency of CD4+PD‐1+HLA‐DR+ T cells is associated with disease progression in CLL

C. Fegan, R. Hills, C. Pepper, 2019, British journal of haematology.

Inﬂuenza A antigen exposure selects dominant V β 17 (cid:1) TCR in human CD8 (cid:1) cytotoxic T cell responses

M. Zambon, A. Boon, L. Borysiewicz, 2001 .

HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells.

Marc S. Cortese, M. Cortese, M. Campo, 2010, Virology.

Limiting dilution analysis of human T cells: a useful clinical tool.

S. Man, E. Kaminski, C. Sharrock, 1990, Immunology today.

Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease

C. Sabin, V. Emery, H. Prentice, 1998, Bone Marrow Transplantation.

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer

S. Stacey, A. Fiander, G. Wilkinson, 1996, The Lancet.

Immunological Responses in Women with Human Papillomavirus Type 16 (HPV-16)-Associated Anogenital Intraepithelial Neoplasia Induced by Heterologous Prime-Boost HPV-16 Oncogene Vaccination

S. H. van der Burg, H. Kitchener, R. Offringa, 2004, Clinical Cancer Research.

Recognition of human tumours: viral antigens as immunological targets for cytotoxic T cells

S. Man, 2001 .

Promiscuous Behavior of HPV16E6 Specific T Cell Receptor Beta Chains Hampers Functional Expression in TCR Transgenic T Cells, Which Can Be Restored in Part by Genetic Modification

C. Meijer, M. Graf, E. Hooijberg, 2010, Cellular oncology : the official journal of the International Society for Cellular Oncology.

Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice.

V. Engelhard, S. Man, J. P. Ridge, 1994, Journal of immunology.

T‐cell response to human papillomavirus type 52 L1, E6, and E7 peptides in women with transient infection, cervical intraepithelial neoplasia, and invasive cancer

W. Yeo, P. Chong, Shih-Jen Liu, 2011, Journal of medical virology.

T-Cell Response to Human Papillomavirus Type 58 L1, E6, and E7 Peptides in Women with Cleared Infection, Cervical Intraepithelial Neoplasia, or Invasive Cancer

W. Yeo, P. Chan, P. Chong, 2010, Clinical and Vaccine Immunology.

Definition of a human T cell epitope from influenza A non-structural protein 1 using HLA-A2.1 transgenic mice.

V. Engelhard, C. J. Luckey, V. Crotzer, 1995, International immunology.

Functional differences between influenza A-specific cytotoxic T lymphocyte clones expressing dominant and subdominant TCR.

L. Borysiewicz, G. Gillespie, P. Moss, 2001, International immunology.

Influenza A antigen exposure selects dominant Vbeta17+ TCR in human CD8+ cytotoxic T cell responses.

M. Zambon, A. Boon, L. Borysiewicz, 2001, International immunology.

Challenges for cancer vaccine development.

S. Man, Z. Tabi, S Man, 2006, Advanced drug delivery reviews.

Activation of CD40 in Cervical Carcinoma Cells Facilitates CTL Responses and Augments Chemotherapy-Induced Apoptosis1

A. Blom, L. Young, A. Eliopoulos, 2004, The Journal of Immunology.

Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes.

L. Borysiewicz, S. Man, E. Evans, 1997, Cancer research.

Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols1

P. Rod Dunbar, Vincenzo Cerundolo, V. Cerundolo, 2002, The Journal of Immunology.

Cancer Vaccines and Immune Monitoring (An Overview)

S. Man, Z. Tabi, 2008 .

Expansion of a CD8+PD-1+ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD4:CD8 Ratios and Disease Progression

C. Fegan, M. Mason, C. Pepper, 2011, Clinical Cancer Research.

Chronic lymphocytic leukaemia: the role of T cells in a B cell disease

S. Man, P. Henley, 2019, British journal of haematology.

Activated B cells mediate efficient expansion of rare antigen-specific T cells.

P. Hillemanns, B. Wollenberg, W. Hammerschmidt, 2007, Human immunology.

Clinical studies of human papilloma vaccines in cervical cancer.

A. Fiander, B. Jasani, L. Borysiewicz, 2001, Advances in experimental medicine and biology.

This information is current as Epitope from Human Papillomavirus 16 E 6 Carcinomas Limit the Presentation of a CTL Antigen Processing Defects in Cervical Cerundolo and

V. Cerundolo, M. Rowe, Matthew Jones, 2001 .

Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R).

A. Fiander, B. Jasani, S. Man, 2003, Vaccine.

Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer.

A. Fiander, B. Jasani, L. Borysiewicz, 2001, Vaccine.

Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7.

M. Rudolf, W. Kast, C. Melief, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Blinatumomab induces autologous T-cell killing of chronic lymphocytic leukemia cells

C. Fegan, P. Brennan, C. Pepper, 2013, Haematologica.

Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial.

C. Hurt, A. Fiander, T. Madden, 2014, The Lancet. Oncology.

T-cell receptor tetramer binding or the lack there of does not necessitate antigen reactivity in T-cell receptor transduced T cells

M. Nishimura, C. Yee, S. Man, 2006, Cancer Immunology, Immunotherapy.

Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III.

A. Fiander, G. Wilkinson, L. Borysiewicz, 1997, Cancer research.

Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides.

D. Hunt, V. Engelhard, S. Man, 1998, Journal of immunology.

Specific MHC-Associated Peptides Lymphocytes Recognize a Complex Array of Class I-Restricted Alloreactive Cytotoxic T

D. Hunt, V. Engelhard, S. Man, 1998 .

Back to the Future: Learning From Cancer Vaccine Trials in Cardiff

S. Man, 2013, Applied immunohistochemistry & molecular morphology : AIMM.

CD8+ T-cell recognition of a synthetic epitope formed by t-butyl modification

C. Fegan, P. Rizkallah, C. Pepper, 2015, Immunology.

CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia

R. Hills, A. Burnett, E. Wang, 2011, Leukemia.

Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial.

H. Kitchener, A. Fiander, S. Man, 2006 .

Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial

H. Kitchener, A. Fiander, S. Man, 2005, International Journal of Gynecologic Cancer.

Cross‐typic specificity and immunotherapeutic potential of a human HPV16 E7‐specific CTL line

S. Man, S. Youde, K. J. Thomas, 2004, International journal of cancer.

CD8+ T-cell responses against oncogenic papillomaviruses – are they useful?

S. Man, 2005 .

Epitope specificity and longevity of a vaccine-induced human T cell response against HPV18

A. Fiander, S. Man, A. Tristram, 2004, International immunology.

Definition of an HPV18/45 cross‐reactive human T‐cell epitope after DNA immunisation of HLA‐A2/KB transgenic mice

S. Man, S. Youde, Corinna McCarthy, 2006, International journal of cancer.

CD8+ T-cell specificity is compromised at a defined MHCI/CD8 affinity threshold

S. Burrows, K. Ladell, E. Gostick, 2016, Immunology and cell biology.

Identification of HLA-DR1- and HLA-DR15-restricted human papillomavirus type 16 (HPV16) and HPV18 E6 epitopes recognized by CD4+ T cells from healthy young women.

S. Man, Kathleen M. E. Gallagher, 2007, The Journal of general virology.

Identification of HLA-DR 1-and HLA-DR 15-restricted human papillomavirus type 16 ( HPV 16 ) and HPV 18 E 6 epitopes recognized by CD 4 + T cells from healthy young women

S. Man, Kathleen M. E. Gallagher, 2007 .

Vaccination Protocols Immune Response Induced by Prime-Boost Competition Between CTL Narrows the

V. Cerundolo, I. Hermans, S. Gilbert, 2002 .

Immunology: Dendritic cells and vaccines

S. Man, 2005 .

The immunosuppressive ligands PD-L1 and CD200 are linked in AML T-cell immunosuppression: identification of a new immunotherapeutic synapse

A. Burnett, S. Knapper, S. Man, 2015, Leukemia.

Synthetic Peptides with Inadvertent Chemical Modifications Can Activate Potentially Autoreactive T Cells

K. Ladell, L. Wooldridge, Sian Llewellyn-Lacey, 2021, The Journal of Immunology.

Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy

M. Evans, S. Man, N. Palaniappan, 2013, Cancer Immunology, Immunotherapy.

Human Cancer Biology Expansion of a CD 8 þ PD-1 þ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD 4 : CD 8 Ratios and Disease Progression

C. Fegan, M. Mason, C. Pepper, 2012 .

Expansion of a CD 8 þ PD-1 þ Replicative Senescence Phenotype in Early Stage CLL Patients Is Associated with Inverted CD 4 : CD 8 Ratios and Disease Progression

C. Fegan, M. Mason, C. Pepper, 2011 .

Sensitivity to inhibition of DNA repair by Olaparib in novel oropharyngeal cancer cell lines infected with Human Papillomavirus

M. Evans, A. Christian, S. Man, 2018, PloS one.

Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology

A. Fiander, L. Morison, L. Borysiewicz, 2005, British journal of cancer.

CD8 + T-cell speci ﬁ city is compromised at a de ﬁ ned MHCI/CD8 af ﬁ nity threshold

S. Burrows, K. Ladell, E. Gostick, 2023 .

Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy

C. Fegan, M. Donia, I. Svane, 2023, Cell.

CD8 + T-cell speci ﬁ city is compromised at a de ﬁ ned MHCI/CD8 af ﬁ nity threshold

S. Burrows, K. Ladell, E. Gostick, 2023 .

Sensitivity of human papillomavirus‑positive and ‑negative oropharyngeal cancer cell lines to ionizing irradiation.

M. Evans, S. Man, Stefan Holzhauser, 2020, Oncology Report.